What is the market doing?
What the tape says about BIOA
BioAge Labs, Inc. is +107% over the past year while the S&P 500 is +20%: 87 points ahead of the market.
+107%
1-year return · S&P 500 +20%
- vs 200-day average
- −41%
vs 200-day average · a clear downtrend
- RSI (14)
- 37
RSI (14) · neutral
- Below its 52-week high
- 61%
Below its 52-week high
Details›
- Last close2026-09-08
- $9.38
- 1 monthS&P 500 −0.30%
- −16%
- 1 yearS&P 500 +20%
- +107%
- vs 50-day average$15.65
- −40%
- 52-week high
- $24.29
- 52-week low
- $4.42
- Annualised volatility
- 103%
| Year | Return |
|---|---|
| 2026 (year to date) | −29% |
| 2025 | +128% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 2 | 1 of 2 | +11% |
| Feb | 2 | 2 of 2 | +9.1% |
| Mar | 2 | 0 of 2 | −20% |
| Apr | 2 | 1 of 2 | +4.0% |
| May | 2 | 1 of 2 | −1.6% |
| Jun | 2 | 2 of 2 | +18% |
| Jul | 2 | 1 of 2 | +1.7% |
| Aug | 2 | 1 of 2 | −22% |
| Sep | 2 | 1 of 2 | +9.0% |
| Oct | 2 | 2 of 2 | +21% |
| Nov | 2 | 1 of 2 | +2.5% |
| Dec | 2 | 1 of 2 | −15% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers - Specialty & Generic
Ranks #8 of 29 by Smart Score